Zai Lab share price today

(ZLAB)

Zai Lab share price is $26.89 & ₹2,290.97 as on 25 Dec 2024, 2.30 'hrs' IST

$26.89

▲

0.35

(1.32%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Zai Lab share price in Dollar and Rupees. Guide to invest in Zai Lab from India. Also see the sentimental analysis on Indian investors investing in Zai Lab. Get details on the Indian mutual funds that are investing in Zai Lab. Get Analyst recommendations and forecasts along with all the Zai Lab's financials.

Zai Lab share price movements

Today's Low: $26.22
Today's High: $27.07
$26.89
2.49%
Downside
Day's Volatility :3.14%
Upside
0.66%
52 Weeks Low: $13.48
52 Weeks High: $36.60
$26.89
49.87%
Downside
52 Weeks Volatility :63.17%
Upside
26.53%

Zai Lab Returns

Period	Zai Lab Ltd	Sector (Health Care)	Index (Russel 2000)
3 Months	18.98%	-8.7%	0.0%
6 Months	53.48%	-5.0%	0.0%
1 Year	3.22%	3.2%	0.0%
3 Years	-59.2%	0.0%	-21.1%

Zai Lab Key Statistics

in dollars & INR

Previous Close	$26.54
Open	$26.58
Today's High	$27.07
Today's Low	$26.22
Market Capitalization	$3.0B
Today's Volume	$116.5K
52 Week High	$36.6
52 Week Low	$13.48
Revenue TTM	$355.7M
EBITDA	$-326.9M
Earnings Per Share (EPS)	$-2.8
Profit Margin	-76.14%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-34.98%

How to invest in Zai Lab from India?

It is very easy for Indian residents to invest directly in Zai Lab from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Zai Lab stock in both Indian Rupees (INR) and US Dollars (USD). Search for Zai Lab or ZLAB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Zai Lab or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Zai Lab shares which would translate to 0.032 fractional shares of Zai Lab as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Zai Lab, in just a few clicks!

Returns in Zai Lab for Indian investors in Rupees

Investment Value

₹1,00,000

Zai Lab investment value today

Current value as on today

₹1,05,651

Returns

₹5,651

(+5.65%)

Returns from Zai Lab Stock

₹3,225 (+3.22%)

Dollar Returns

₹2,426 (+2.43%)

Indian investors sentiment towards Zai Lab

-19%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Zai Lab on INDmoney from India has reduced in the last 30 days as on Dec 26, 2024. -19% less investors are searching Zai Lab in the last 30 days versus the previous period.

Global Institutional Holdings in Zai Lab

HHG PLC
8.15%
Wellington Management Company LLP
7.85%
Capital World Investors
5.99%
Viking Global Investors LP
1.81%
BAMCO Inc
1.77%
T. Rowe Price Associates, Inc.
1.68%

Analyst Recommendation on Zai Lab

Buy

83%Buy

16%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Zai Lab(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Zai Lab

What analysts predicted

Upside of 94.84%

Current:

$26.89

Target:

$52.39

Insights on Zai Lab

Price Movement
In the last 3 months, ZLAB stock has moved up by 32.2%
Increasing Revenue
Revenue is up for the last 4 quarters, 65.83M → 102.26M (in $), with an average increase of 13.2% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -80.27M → -41.67M (in $), with an average increase of 92.6% per quarter
ZLAB vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.3% return, outperforming this stock by 21.0%
ZLAB vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 84.4%
Price to Sales
ForZLAB every $1 of sales, investors are willing to pay $7.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Zai Lab Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$129.5K	-
Net Income	$-139.1M	↑ 176.03%
Net Profit Margin	-107.4K%	-

	FY19	Y/Y Change
Revenue	$13.0M	↑ 9930.55%
Net Income	$-183.4M	↑ 31.85%
Net Profit Margin	-1.4K%	↑ 106021.4%

	FY20	Y/Y Change
Revenue	$49.0M	↑ 277.04%
Net Income	$-298.2M	↑ 62.6%
Net Profit Margin	-609.02%	↑ 803.14%

	FY21	Y/Y Change
Revenue	$144.3M	↑ 194.77%
Net Income	$-692.4M	↑ 132.24%
Net Profit Margin	-479.82%	↑ 129.2%

	FY22	Y/Y Change
Revenue	$215.0M	↑ 49.01%
Net Income	$-482.0M	↓ 30.39%
Net Profit Margin	-224.14%	↑ 255.68%

	FY23	Y/Y Change
Revenue	$266.7M	↑ 24.03%
Net Income	$-334.6M	↓ 30.58%
Net Profit Margin	-125.46%	↑ 98.68%

	Q2 FY23	Q/Q Change
Revenue	$68.9M	↑ 9.66%
Net Income	$-120.9M	↑ 320.27%
Net Profit Margin	-175.56%	↓ 129.75%

	Q3 FY23	Q/Q Change
Revenue	$69.2M	↑ 0.53%
Net Income	$-69.2M	↓ 42.8%
Net Profit Margin	-99.89%	↑ 75.67%

	Q4 FY23	Q/Q Change
Revenue	$65.8M	↓ 4.91%
Net Income	$-95.4M	↑ 38.0%
Net Profit Margin	-144.96%	↓ 45.07%

	Q1 FY24	Q/Q Change
Revenue	$87.1M	↑ 32.38%
Net Income	$-53.5M	↓ 43.97%
Net Profit Margin	-61.36%	↑ 83.6%

	Q2 FY24	Q/Q Change
Revenue	$100.5M	↑ 15.32%
Net Income	$-80.3M	↑ 50.13%
Net Profit Margin	-79.87%	↓ 18.51%

	Q3 FY24	Q/Q Change
Revenue	$102.3M	↑ 1.75%
Net Income	$-41.7M	↓ 48.09%
Net Profit Margin	-40.75%	↑ 39.12%

	FY18	Y/Y Change
Profit	$85.9K	-

	FY19	Y/Y Change
Profit	$9.2M	↑ 10656.73%

	FY20	Y/Y Change
Profit	$32.2M	↑ 248.88%

	FY21	Y/Y Change
Profit	$92.1M	↑ 185.75%

	FY22	Y/Y Change
Profit	$141.0M	↑ 53.16%

	FY23	Y/Y Change
Profit	$170.9M	↑ 21.19%

	Q2 FY23	Q/Q Change
Profit	$45.1M	↑ 8.78%

	Q3 FY23	Q/Q Change
Profit	$43.7M	↓ 3.0%

	Q4 FY23	Q/Q Change
Profit	$40.6M	↓ 7.21%

	Q1 FY24	Q/Q Change
Profit	$53.5M	↑ 31.87%

	Q2 FY24	Q/Q Change
Profit	$65.3M	↑ 21.93%

	Q3 FY24	Q/Q Change
Profit	$65.3M	↑ 0.12%

	FY18	Y/Y Change
Operating Cash Flow	$-97.5M	↑ 201.35%
Investing Cash Flow	$-212.6M	↑ 1937.13%
Financing Cash Flow	$144.1M	↓ 23.27%

	FY19	Y/Y Change
Operating Cash Flow	$-191.0M	↑ 95.83%
Investing Cash Flow	$-14.9M	↓ 92.99%
Financing Cash Flow	$219.3M	↑ 52.14%

	FY20	Y/Y Change
Operating Cash Flow	$-216.1M	↑ 13.11%
Investing Cash Flow	$-554.8M	↑ 3625.69%
Financing Cash Flow	$1.1B	↑ 416.38%

	FY21	Y/Y Change
Operating Cash Flow	$-549.2M	↑ 154.21%
Investing Cash Flow	$250.0M	↓ 145.05%
Financing Cash Flow	$820.2M	↓ 27.57%

	FY22	Y/Y Change
Operating Cash Flow	$-367.6M	↓ 33.06%
Investing Cash Flow	$420.0M	↑ 68.04%
Financing Cash Flow	$-1.7M	↓ 100.21%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-58.7M	↓ 15.28%
Investing Cash Flow	$42.7M	↑ 0.0%
Financing Cash Flow	$-1.5M	↓ 61.58%

Zai Lab Technicals Summary

Sell

Neutral

Buy

Zai Lab is currently in a neutral trading position according to technical analysis indicators.

Zai Lab Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Zai Lab Ltd	-4.27%	53.48%	3.22%	-59.2%	-33.47%
Regeneron Pharmaceuticals, Inc.	-4.68%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-5.49%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.08%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-11.59%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Zai Lab Ltd	NA	NA	NA	-2.5	-0.35	-0.21	NA	6.8
Regeneron Pharmaceuticals, Inc.	17.7	17.7	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Zai Lab Ltd	Buy	$3.0B	-33.47%	NA	-76.14%
Regeneron Pharmaceuticals, Inc.	Buy	$78.6B	91.19%	17.7	33.61%
Biontech Se	Buy	$27.2B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.2B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$104.4B	86.41%	32.84	-4.51%

About Zai Lab

zai lab is a biopharmaceutical company dedicated to discovering, developing and commercializing innovative medicines. our vision is to address the largest unmet medical needs and transform patients’ lives around the world. we take a unique approach to combine both in-licensed products and internal r&d; to achieve a rich pipeline. we believe our drug candidates can be truly disease modifying and bring significant benefits to patients. the company was founded in 2013 by a group of industry veterans. the founders are known as pioneers in china’s fast advancing biotech industry with a proven track record for successful chinese cfda and us fda filings and approvals. our senior management team introduced fast regulatory approval pathways in china and developed a variety of partnership models with multinational pharmaceutical companies. we endeavor to conduct world class clinical development in china and beyond. zai lab has strong backing from a leading group of healthcare investors. our inve

Organization	Zai Lab
Employees	2175
CEO	Dr. Ying Du Ph.D.
Industry	Health Technology

Management People of Zai Lab

Name	Title
Dr. Ying Du Ph.D.	Founder, Chairperson & CEO
Mr. Joshua L. Smiley	President & COO
Dr. Rafael G. Amado M.D.	President and Head of Global Research & Development
Dr. Yajing Chen Ph.D.	Chief Financial Officer
Dr. Peter Huang Ph.D.	Chief Scientific Officer
Ms. Christine Chiou	Senior VP & Head of Investor Relations
Mr. Frazor Titus Edmondson III, J.D.	Chief Legal Officer & Joint Corporate Secretary
Dr. Ning Xu M.D.	Executive VP & Head of Clinical Operations
Dr. Jonathan J. Wang MBA, Ph.D.	Chief Business Officer
Dr. James Yan DABT, M.D., Ph.D.	Chief Operating Officer of R&D

Important FAQs about investing in Zai Lab from India :

What is Zai Lab share price today?

Zai Lab share price today stands at $26.89, Open: $26.58 ; Previous Close: $26.54 ; High: $27.07 ; Low: $26.22 ; 52 Week High: $36.60 ; 52 Week Low: $13.48. The stock opens at $26.58, after a previous close of $26.54. The stock reached a daily high of $27.07 and a low of $26.22, with a 52-week high of $36.60 and a 52-week low of $13.48.

Can Indians buy Zai Lab shares?

Yes, Indians can invest in the Zai Lab (ZLAB) from India.

With INDmoney, you can buy Zai Lab at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Zai Lab at zero transaction cost.

How can I buy Zai Lab shares from India?

It is very easy to buy Zai Lab from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Zai Lab be purchased?

Yes, you can buy fractional shares of Zai Lab with INDmoney app.

What are the documents required to start investing in Zai Lab stocks?

To start investing in Zai Lab, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.